Exelixis
EXEL
#1314
Rank
โ‚น1.615 T
Marketcap
โ‚น6,621
Share price
-1.73%
Change (1 day)
80.35%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company